VERORAB

This brand name is authorized in Ecuador, Estonia, Hong Kong SAR China, Israel, Lithuania, Nigeria, Poland, Romania, South Africa.

Active ingredients

The drug VERORAB contains one active pharmaceutical ingredient (API):

1	Rabies vaccine
	Read more about Rabies vaccine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J07BG01	Rabies, inactivated, whole virus	J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BG Rabies vaccines
Discover more medicines within J07BG01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	18.192-2-05-11
EE	Ravimiamet	1019562, 1066238, 1781210
HK	Department of Health Drug Office	53345
IL	מִשְׂרַד הַבְּרִיאוּת	7529
LT	Valstybinė vaistų kontrolės tarnyba	1014032, 1014033, 1072479, 1086910
NG	Registered Drug Product Database	A6-0154
Switch country to Nigeria in order to find specific presentations of VERORAB
PL	Rejestru Produktów Leczniczych	100224430
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W13416001, W13416002, W13416003, W13416004
ZA	Health Products Regulatory Authority	V/30.1/220